Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug Looms Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday ...

Vertex beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday. Meet the Newest Addition to the S&P 500. The Stock Has Soared 845 ...

I reviewed an almost identical product many years ago for the reef market so it isn’t new, and when I see a product with that premium Vertex badge on it, I’d like to think its research and development ...

Coolmate, a Vietnamese ecommerce direct-to-consumer (D2C) men's apparel brand, has secured $6 million in Series B funding led by Vertex Ventures Southeast Asia & India. The funding is set to accel ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? The one silver-lining of signing on to take Accutane (an oral retinoid ...

But there was one company that kept at it. Fast-forward to today, and Vertex Pharmaceuticals is on the verge of gaining an FDA approval for suzetrigine (VX-548), a nonaddictive oral treatment that ...

Vertex Pharmaceuticals (VRTX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known ...

The IDF confirmed the operation focused strictly on military targets, steering clear of nuclear and oil facilities to prevent wider conflict escalation. An F-35 Adir from the 140th squadron takes ...

Vertex Pharmaceuticals is in the process of getting a new painkiller approved. It just published some data that suggests the candidate will be quite profitable. But regulators still need to sign ...

BLB&B Advisors LLC boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 23.4% in the third quarter, according to its most recent filing with the SEC.